Wolfman J, Baumal R, Marks A
Cancer Res. 1985 Dec;45(12 Pt 1):6341-6.
Interspecies somatic cell hybrids formed between a clone of Lewis lung carcinoma (LLC/9) and Chinese hamster ovary cells were assessed for tumorigenicity in C57BL/6 mice and capacity to protect mice against a challenge with LLC/9 cells. LLC/9 cells were fused with ouabain-resistant-Chinese hamster ovary cells deficient in hypoxanthine guanine phosphoribosyl transferase. Hybrids were selected in medium supplemented with hypoxanthine: aminopterin: thymidine and 5 mM ouabain. Hybrids were shown to contain chromosomes and surface antigens of both parents. At doses up to 10(7) cells, uncloned hybrids and hybrid clones obtained by limiting dilution were nontumorigenic in C57BL/6 mice, while 10(4) LLC/9 cells were tumorigenic in 80% of mice. In protection experiments, hybrid cells were injected i.p., followed by foot pad challenge with 10(6) LLC/9 cells. Three injections of live uncloned hybrids produced complete protection, while one or two injections gave partial protection. Individual live hybrid clones conferred no or partial but never complete protection. Administration of hybrids or LLC cells killed by freezing and thawing or arrested in division by treatment with mitomycin C failed to confer protection against subsequent challenge with LLC/9 cells. These LLC/9 X CHO hybrid cells will be useful for studying therapy of primary LLC tumors and their pulmonary metastases.
评估了Lewis肺癌克隆(LLC/9)与中国仓鼠卵巢细胞形成的种间体细胞杂种在C57BL/6小鼠中的致瘤性以及保护小鼠抵抗LLC/9细胞攻击的能力。LLC/9细胞与缺乏次黄嘌呤鸟嘌呤磷酸核糖转移酶的哇巴因抗性中国仓鼠卵巢细胞融合。在补充有次黄嘌呤:氨基蝶呤:胸腺嘧啶核苷和5 mM哇巴因的培养基中选择杂种。已证明杂种含有双亲的染色体和表面抗原。在剂量高达10⁷个细胞时,未克隆的杂种和通过有限稀释获得的杂种克隆在C57BL/6小鼠中无致瘤性,而10⁴个LLC/9细胞在80%的小鼠中具有致瘤性。在保护实验中,腹腔注射杂种细胞,随后用10⁶个LLC/9细胞进行足垫攻击。三次注射活的未克隆杂种产生完全保护,而一次或两次注射则产生部分保护。单个活的杂种克隆不提供保护或提供部分保护,但从未提供完全保护。给予经冻融杀死或用丝裂霉素C处理使其停止分裂的杂种或LLC细胞不能提供针对随后LLC/9细胞攻击的保护。这些LLC/9×CHO杂种细胞将有助于研究原发性LLC肿瘤及其肺转移的治疗。